Background-We evaluate sex-based differences in the effectiveness of early cardiac computed tomographic angiography (CCTA) and standard emergency department (ED) evaluation in patients with acute chest pain. Methods and Results-In the Rule-Out Myocardial Infarction With Computer-Assisted Tomography (ROMICAT)-II multicenter, controlled trial, we randomized 1000 patients (47% women) 40 to 74 years of age with symptoms suggestive of acute coronary syndrome to an early CCTA or standard ED evaluation. In this prespecified analysis, women in the CCTA arm had a greater reduction in length of stay, lower hospital admission rates, and lesser increased cumulative radiation dose than men in a comparison of ED strategies (P for interaction ≤0.02). Although women had lower acute coronary syndrome rates than men (3% versus 12%; P<0.0001), sex differences in length of stay persisted after adjustment for baseline differences, including acute coronary syndrome rate (P for interaction <0.03). Length of stay was similar between sexes with normal CCTA findings (P=0.11). There was no missed acute coronary syndrome for either sex. No difference was observed in major adverse cardiac events between sexes and ED strategies (P for interaction =0.39). Women had more normal CCTA examinations than men (58% versus 37%; P<0.0001), less obstructive coronary disease by CCTA (5% versus 17%; P=0.0001), but similar normalcy rates for functional testing (P=0.65). Men in the CCTA arm had the highest rate of invasive coronary angiography (18%), whereas women had comparable low 5% rates regardless of ED strategy. Conclusions-This trial provides data supporting an early CCTA strategy as an attractive option in women presenting to the ED with symptoms suggestive of acute coronary syndrome. The findings may be explained by lower CAD prevalence and severity in women than men.
C oronary artery disease (CAD) is a leading cause of mortality for women in the United States, with poorer prognosis than for men. 1 Contrast-enhanced cardiac computed tomographic angiography (CCTA) is an advanced noninvasive imaging modality with excellent diagnostic accuracy for the detection of CAD. [2] [3] [4] Recently, 3 large multicenter trials showed that CCTA implemented early in the emergency department (ED) evaluation of chest pain was a safe alternative compared with standard ED evaluation and was associated with reduced length of stay (LOS).
Controversy remains as to whether patient subgroups at relatively low risk for CAD merit noninvasive testing, especially involving cardiac imaging, when presenting to the ED with chest pain. 8 Women in particular are known to be at lower risk for having CAD compared with age-matched men. 1, 9 Moreover, women have higher rates of false-positive or indeterminate exercise testing as a result of nonspecific ST-T-wave abnormalities and breast attenuation on nuclear imaging that may simulate anterior segment myocardial ischemia. 9 Because CCTA directly visualizes CAD, it may be particularly beneficial in women, especially in those <65 years of age. 10 However, societal concerns exist about the potential increased risk of breast cancer from radiation exposure of a CCTA and other imaging tests, particularly in younger women. 8, 11 In this prespecified analysis from the recently reported Rule-Out Myocardial Infarction with Computer-Assisted Tomography (ROMICAT)-II trial, we aimed to determine whether sex is associated with differences in effectiveness and safety, including radiation exposure, of an early CCTA versus standard ED evaluation in patients presenting to the ED with chest pain suggestive of acute coronary syndrome (ACS). We also examined whether results of diagnostic testing could explain any such observed differences.
Methods

Study Population and Protocol
ROMICAT-II was a randomized, multicenter, controlled trial consisting of 1000 patients at 9 US sites who presented to the ED during weekday daytime hours with symptoms suggestive of ACS but without ischemic ECG changes or initial positive troponin. The study design, inclusion and exclusion criteria, and primary results have been reported previously. 5, 12 The study was approved by the institutional review board at each participating site, and all participants provided informed consent. Briefly, eligible patients were between the ages of 40 and 74 years, had chest pain or anginal equivalent of at least 5 minutes duration within 24 hours of ED presentation, were in sinus rhythm, and warranted further risk stratification to rule out ACS. Major exclusion criteria were history of known CAD, new diagnostic ischemic changes on the initial ECG, initial troponin in excess of the 99th percentile of the local assay, impaired renal function (creatinine >1.5 mg/dL), hemodynamic or clinical instability, known allergy to iodinated contrast agent, body mass index >40 kg/m 2 , or currently symptomatic asthma. All patients were randomized either to CCTA as part of the initial evaluation or to the standard ED evaluation strategy, as dictated by local caregivers. CCTA was performed with at least 64-slice CT technology, and both retrospectively ECG-gated and prospectively ECG-triggered CCTA protocols were allowed. The standard ED evaluation strategy was performed at the discretion of the local caregivers and included no diagnostic testing, functional testing (exercise treadmill test, exercise or pharmacological nuclear imaging, stress echocardiography), or invasive coronary angiography. Patients discharged within 24 hours of ED presentation were contacted by phone within 72 hours to evaluate for potential missed ACS. Patients were followed up for 28 days after discharge from the ED or hospital by phone interview and queried as to repeat ED visits or hospitalizations for recurrent chest pain, diagnostic testing/ interventions, and major adverse cardiac events with verification of medical records. This prespecified analysis focused on comparing differences between women and men in the effectiveness and safety end points of implementing an early CCTA strategy versus standard ED evaluation.
End Points
The primary end point was the LOS, defined as the time from ED presentation to the time of the discharge order. Secondary effectiveness end points included rates of direct ED discharge (defined as the proportion of patients discharged from the ED without admission to an observation unit or hospital), hospital admission, and downstream testing (defined as ≥2 diagnostic tests, which included CCTA, exercise treadmill test, nuclear stress test, stress echocardiography, transthoracic echocardiography, and invasive coronary angiography). Additional secondary end points included rates of invasive coronary angiography, revascularization (percutaneous coronary intervention or coronary arterial bypass surgery), and repeat ED or hospitalization for recurrent chest pain at 28 days. Safety end points included missed ACS (defined as an unexpected cardiovascular event within 72 hours after hospital discharge in patients with a hospital stay of <24 hours) and major adverse cardiac events (defined as death, myocardial infarction [MI], unstable angina, or urgent coronary revascularization that occurred within 28 days). Radiation exposure from testing was calculated (in mSv) for CCTA, nuclear perfusion imaging, and invasive coronary angiography using standard methods, 13 including a conversion coefficient of 0.014 for the chest for CCTA scans. Cumulative radiation dose was defined as the mean radiation dose during the index evaluation and follow-up period.
Statistical Analysis
Descriptive statistics were expressed as mean±SD or median with interquartile range for continuous variables and as frequency and percentages for nominal variables. To compare differences between groups, we used the Fisher exact test for categorical variables and the Student t test for continuous variables as appropriate. We used logistic regression or exact logistic regression to test the interaction between sex and randomized evaluation strategies for binary outcomes and ANOVA or quantile regression for continuous outcomes as appropriate. For adjusted analyses of the sex interaction and randomized ED strategies on mean and median LOS, we controlled for age, cardiac risk factors (hypertension, diabetes mellitus, dyslipidemia, smoking, family history of premature CAD), and other covariates that were different between men and women (race, β-blocker medication, diastolic blood pressure, and ACS prevalence). We used the Student t test to compare the mean effective radiation dose between groups and ANOVA to test the interaction between sex and randomized evaluation strategies. Two-tailed values of P and P for interaction <0.05 were considered to indicate statistical significance. All analyses were performed with SAS (version 9.2; SAS Institute Inc, Cary, NC). Drs Truong, Hayden, and Hoffmann had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Results
Study Population
Of the 1000 patients, there were 468 women (47%) and 532 men (53%). Of the 501 patients in the CCTA arm, 239 were women and 262 were men. Of the 499 patients in the standard evaluation arm, 229 were women and 270 were men. Table 1 gives the baseline characteristics of the ROMICAT-II trial participants as stratified by sex and randomized ED strategies. There were no differences in baseline characteristics by randomized evaluation strategies in men or in women (all P>0.05). Overall, women were older, were more frequently black, more often had diabetes mellitus, and were more often on β-blocker medication compared with men (all P≤0.03). Conversely, fewer women were white and smokers compared with men (both P<0.01). Initial ED presentations were similar between sexes (all P≥0.37) except that women had lower diastolic blood pressure (P<0.0001). Women had higher rates of noncardiac chest pain than men (P<0.0001). Importantly, women had a lower rate of ACS as a final diagnosis than men (3% versus 12%; P<0.0001), although there was no difference in ACS rate by randomization strategies of CCTA versus standard ED evaluation in women (3% versus 3%; P=1.0) or men (14% versus 10%; P=0.14; P for interaction=0.46). Table 2 shows sex differences in end points between evaluation strategies. For either mean or median LOS (Figure 1 ), women had a greater reduction in LOS than men when CCTA was used compared with standard evaluation. Compared with (3) 7 (3) 12 (4) Ethnicity, Hispanic, or Latino, n (%) 32 (13) 29 (13) 27 (10) 39 (14) Cardiovascular risk factors n (%) ACS indicates acute coronary syndrome; CABG, coronary artery bypass graft; CCTA, cardiac computed tomography angiography; CP, chest pain; ED, emergency department; MACE, major adverse cardiovascular event; and PCI, percutaneous coronary intervention.
Primary and Secondary Effectiveness End Points
*P for interaction for median LOS.
by guest on April 15, 2017 http://circ.ahajournals.org/ Downloaded from the standard ED evaluation, an early CCTA strategy resulted in a 13.6-hour shorter mean LOS in women versus a 2.2-hour difference in men (P for interaction=0.006). Using median LOS, implementing an early CCTA strategy resulted in a 19.4-hour shorter median LOS for women and a 16.6-hour reduction for men (P for interaction=0.0005). The sex difference in the effects of evaluation strategy on mean and median LOS persisted after adjustments for baseline sex differences, including age, cardiac risk factors, and ACS rate (all P for interaction <0.03). A similar sex difference was seen with logtransformed LOS. Direct ED discharge was >3 times as high with early CCTA as with standard evaluation in both sexes. In contrast, hospital admission rates in women were reduced by nearly half in the CCTA arm versus standard evaluation but did not differ by arm in men (P for interaction=0.005).
Downstream testing at both the index visit and the 28-day follow-up was more common in the CCTA arm in both men and women, with no significant interactions by sex. There was also no interaction by sex in evaluation strategies for invasive coronary angiography, percutaneous coronary intervention, or recurrent chest pain hospitalizations (all P for interaction ≥0.08). Invasive coronary angiography was nearly twice as common in men with the early CCTA strategy (18%) compared with standard evaluation but was comparably low at 5% in women, regardless of randomized evaluation strategy, both during the index visit and at the 28-day follow-up. It is noteworthy that men in the CCTA arm had the highest prevalence of downstream testing, including invasive coronary angiography and percutaneous coronary intervention.
Safety End Points
There was no missed ACS for either sex. There was no difference between sex and randomized ED strategies for 28-day major adverse cardiac events (P for interaction=0.39), although the number of events was very low in each of the groups. Table 3 shows the test results as stratified by sex. Of note, women had more normal CCTA examinations than men (58% versus 37%; P<0.0001) but had similar normalcy rates for functional testing (86% versus 84%; P=0.65). There was no difference in mean LOS between sexes when the CCTA findings were normal (P=0.11; Figure 2 ). Of the patients in the CCTA arm, the proportion of women with no CAD or nonobstructive CAD was higher than the proportion of men (90% versus 80%; P=0.005), whereas women had a lower rate of obstructive epicardial coronary disease than men (5% versus 17%; P=0.0001). Figure 3 shows the effective cumulative radiation dose by randomized ED strategies and its corresponding cumulative 28-day dose as stratified by sex. As might be predicted, in both men and women, the early CCTA strategy resulted in higher cumulative radiation exposure at the index visit and at the 28-day follow-up (all P<0.0001). However, cumulative radiation dose was higher in men than women in the CCTA arm at both time points (both P for interaction ≤0.02). Notably, in the standard ED arm, 347 patients (70%) had either an initial diagnostic test with no radiation exposure (138 patients had exercise treadmill test and 100 patients with stress echocardiography) or no testing at all (n=109, 22%). Additionally, there were more patients who did not undergo a diagnostic test in the standard ED evaluation than in the CCTA arm (women: 19% with no diagnostic test in standard evaluation versus 2% in the CCTA arm; men: 24% in the standard evaluation versus 2% in the CCTA arm; both P<0.0001; P for interaction=0.39). Table 4 summarizes the effective radiation dose by initial diagnostic testing modality and the subsequent Figure 1 . Length of stay (LOS) as stratified by randomized emergency department (ED) evaluation strategy and by sex. Women had shorter LOS compared with men when an early cardiac computed tomographic angiography (CCTA) strategy was implemented compared with standard ED evaluation (mean Δ 11.5 hours; P for interaction=0.006; median Δ2.8 hours; P for interaction=0.0005). cumulative radiation dose at the index visit and the 28-day follow-up as stratified by sex. In general, women undergoing CCTA received a lower radiation dose than men. Interestingly, in women who were scanned with the newest 128-slice dual-source CT scanner technology (which was available at 3 of the 9 clinical sites), the mean cumulative radiation dose was low and similar between the CCTA and standard ED strategies (5.8 versus 5.0 mSv; P=0.69). In men, however, the mean cumulative radiation dose at the 28-day follow-up remained higher in the CCTA arm compared with standard evaluation (12.9 versus 5.6 mSv; P<0.0001; P for interaction=0.01) despite the use of newer CT scanner technology.
Initial Diagnostic Testing Results
Radiation Exposure
Discussion
In this prespecified analysis of the ROMICAT-II trial, women had a greater reduction in LOS than men when early CCTA was used in the ED evaluation of chest pain suggestive of ACS. Women in the CCTA arm also had a lower hospital admission rate and a lesser increase in cumulative radiation dose than men. We also observed that men in the CCTA arm had the highest rate of invasive coronary angiography (18%), whereas women had comparable low 5% rates, regardless of ED strategies. Given that both sexes had similar LOS if CCTA results were normal, these findings may be explained largely by a lower burden of CAD in women, in whom there was a higher normal CCTA rate compared with men (58% versus 37%) and a lower rate of obstructive coronary disease by CCTA (5% versus 17%). This difference in CAD prevalence and severity in women observed in the CCTA arm allowed for their earlier discharge from the hospital and resulted in fewer downstream tests and procedures than men, including invasive coronary angiography and percutaneous coronary intervention, which contributed to the finding of lower increased radiation dose in women.
It is important to note that awareness of heart disease risk remains underrecognized among women, with only 54% recognizing cardiac disease as their leading cause of mortality in the United States.
14 Because CCTA is able to visualize nonobstructive CAD, which is typically not detectable during stress testing, it could be argued that both women and men could benefit from a more aggressive primary prevention regimen such as statin therapy. Moreover, CCTA in this symptomatic ED cohort detected coronary atherosclerosis in more than one third of women (32% nonobstructive and 5% obstructive CAD), which is associated with long-term adverse outcomes compared with individuals free of CAD, 15, 16 providing greater motivation to treat modifiable coronary risk factors. Conversely, a normal CCTA examination, which was found in 58% of women in our study who underwent CCTA, has a major adverse cardiac event-free warranty period of at least 2 years with a very favorable prognosis and hence provides useful information if patients present again to the ED within this time frame. 15, 16 These potential benefits of CCTA need to be evaluated in the context of its risks, particularly radiation exposure. Overall, 70% of patients in the standard evaluation arm received no diagnostic testing (22%) or initial tests without radiation exposure (exercise treadmill test or stress echocardiography). Not surprisingly, the cumulative radiation dose was lowest for those whose initial diagnostic test did not require ionizing radiation. Although cumulative radiation exposure was higher for both sexes in the CCTA arm compared with standard evaluation, women had less increased radiation exposure than men. Our data also shows that use of newer CCTA technology results in significant lowering of radiation exposure in the CCTA arm to doses comparable to those with the standard evaluation, especially for women (≈5 mSv). In comparison, the effective radiation dose from a nuclear stress test was ≈15 mSv. Although radiation dose concern from estimating lifetime attributable risk of cancer suggests a linkage between CCTA and increased risk for breast cancer in women, 11 the validity and conclusions of such a model-based report have been questioned by the American Association of Physicists in Medicine 17 and may be inconsequential, with doses approaching the annual background radiation dose of ≈3 mSv. 13 Further efforts in using dose-saving algorithms in conjunction with the newest CT scanner technology could reduce the radiation dose to ≤3 mSv. 18, 19 
Limitations
The study has several notable limitations. Although the adjusted analyses provide additional support to strengthen our findings that there are sex-specific treatment effects on LOS, potential confounders may still exist. We were limited by the small number of patients who underwent coronary revascularization to show statistically significant differences by sex. The small number of major adverse events in this low-intermediate risk sample precludes definitive conclusions as to whether there is a greater benefit for women than men undergoing CCTA. The lack of follow-up beyond 28 days in this trial limits the ability to examine potential longer-term benefits of a CCTA strategy in the ED. The newest CT scanners may not be commonly available in practice. Because the sample size for the assessment of radiation exposure using the newest CT scanner technology is relatively small, this interaction should be interpreted with caution. However, in addition to the 128-slice dual-source CT scanner, other CT platforms have the capability of radiation dose reduction. 
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Conclusions
In the ED evaluation of low-intermediate risk patients with chest pain suggestive of ACS, women undergoing CCTA compared with a standard evaluation strategy have a greater reduction in LOS and hospital admissions compared with men, comparable low invasive coronary angiography rates between ED strategies, and hence a lesser increased cumulative radiation dose compared with men. These findings may be explained by the lower CAD prevalence and severity in women than men and provide support that an early CCTA strategy is an attractive alternative in women with such symptoms.
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Disclosures
CLINICAL PERSPECTIvE
State-of-the art imaging with cardiac computed tomography angiography (CCTA) provides a safe alternative to reduce length of stay for patients presenting to the emergency department with symptoms suggestive of acute coronary syndrome. Controversy remains as to whether patients at relatively low risk for coronary artery disease merit noninvasive testing, especially involving cardiac imaging. Women are known to be at lower risk for coronary disease than men, yet they have more frequent false-positive stress tests. Issues surrounding increased radiation exposure and more frequent downstream testing, including invasive coronary angiography, remain a concern for clinicians in the widespread implementation of CCTA. In this prespecified analysis from the multicenter, randomized, controlled Rule-Out Myocardial Infarction With Computer-Assisted Tomography (ROMICAT)-II trial of 1000 low-intermediate risk patients who presented to the emergency department with symptoms suggestive of acute coronary syndrome, we compared sex differences in the effectiveness of an early CCTA and standard emergency department evaluation. Women undergoing an early CCTA strategy compared with a standard evaluation strategy have a greater reduction in length of stay and hospital admissions than men. Although men in the CCTA arm have the highest rate of invasive coronary angiography, women have comparable low invasive angiography rates regardless of emergency department strategies and thus lower increased cumulative radiation dose than men. The findings may be explained by lower coronary artery disease prevalence and severity in women, with more normal CCTA and a lower rate of obstructive epicardial coronary disease than men. These data provide support for clinicians to use an early CCTA strategy in women with such symptoms.
